Dr. Szilvia Molitorisz, MD

Dr. Molitorisz practices at Concord Medical Center in Concord, California, part of John Muir Health.

Dr. Molitorisz's NPI, 1295806289, was assigned on November 13, 2006. Dr. Molitorisz graduated from Semmelweis University in 1991. Dr. Molitorisz holds California license C55767.

Dr. Molitorisz's primary practice is Concord Medical Center, at 2540 East St, Concord, CA 94520 in Contra Costa County. The practice phone is (925) 682-8200.

Dr. Molitorisz's primary practice is Concord Medical Center in Concord, California, part of John Muir Health. Dr. Molitorisz is also affiliated with Sutter Medical Center, Sacramento. The medical group on file is BASS Medical Group. Dmand AI also links Dr. Molitorisz to 3 more hospitals, 2 group practices and clinics and 2 medical groups, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Molitorisz practices, 7 sites in all. Vendor and product names are available with a free account.

Infectious disease is Dr. Molitorisz's primary specialty in the NPI Registry, under taxonomy code 207RI0200X. Dr. Molitorisz is board certified in infectious disease by the American Board of Internal Medicine. Dmand AI has Dr. Molitorisz's licenses on file in 4 states: California, Mississippi, Iowa and Michigan.

Dmand AI lists acute skin infection, ankle or foot injury, cold sores or genital herpes, endocarditis, joint or bone infection, minor injury to a limb, pneumonia and vaginal infection among the conditions Dr. Molitorisz treats.

CMS data shows 1,460 Medicare services from Dr. Molitorisz across 5 procedure codes in 2024, for 520 Medicare patients. Medicare paid $164,138 for them.

CMS counts 520 Medicare patients who saw Dr. Molitorisz in 2024. The largest group is 65 to 74, with 178 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 48% are also on Medicaid. Their average risk score is 3.67, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Molitorisz's median patient age at 62, with 43% women.

In 2024, Dr. Molitorisz wrote 181 Medicare Part D claims for 36 patients. 94% of them were for generic drugs. CMS names the drug for 139 of them, across 8 drugs with 11 or more claims each, at $5,543 in total drug cost. In 2023, CMS named 61 claims across 3 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 96 out of 100 for Dr. Molitorisz for performance year 2024, reported individually. Dr. Molitorisz accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Molitorisz as offering telehealth.

CMS Open Payments shows 10 general payments to Dr. Molitorisz from 5 drug and device companies from 2017 to 2025. Food and beverage make up the largest share, 92% of the total. Merck Sharp & Dohme Corporation paid the most, $158.

Dr. Molitorisz graduated from Semmelweis University in 1991.

Dr. Molitorisz is in network with 13 carriers, including Aetna, Blue Cross Blue Shield of Michigan and United Healthcare. PPO plans come from the most carriers, 8. Check the plan with the practice before a visit.